Park Medi World IPO Day 1: Check Latest GMP, Subscription Status, Key Highlights, and More
The second-largest private hospital chain in North India, Park Medi World, has launched its Initial Public Offering (IPO) for public subscription today, December 10, 2025. One day before the IPO opening, the company raised ₹276 crore from 23 anchor investors on December 9, 2025.
Park Medi World IPO: Issue Details
Issue Type: The Park Medi World IPO is a book-building issue of ₹920 crore, consisting of a fresh issue of ₹770 crore and an offer for sale (OFS) of ₹150 crore.
Lot Size: 92 shares
Price Band: ₹154-₹162 per share
Minimum Investment: ₹14,168 (for retail investors
IPO Closing Date: December 12, 2025
Allotment Date: The basis of allotment will be finalised by December 15, 2025.
Listing Date: The tentative listing date on BSE and NSE is December 17, 2025.
Book Running Lead Manager: Nuvama Wealth Management Ltd.
Registrar: Kfin Technologies Ltd.
Park Medi World IPO Day 1 Subscription Status
[10-December-2025 11:57:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.00 |
|
Non-Institutional Investors |
0.18 |
|
Retail Individual Investors (RIIs) |
0.22 |
|
Total |
0.15 |
Utilisation of IPO Proceeds
The net proceeds from the fresh issue will be used towards the following objectives:
- General corporate purposes
- Fund capital expenditure for
- Development of a new hospital by the subsidiary, Park Medicity (NCR)
- Purchase of medical equipment by the company and subsidiaries, Blue Heavens and Ratangiri
- Repay/prepay outstanding borrowings availed by the company and its subsidiaries
- Unidentified inorganic acquisition
Park Medi World IPO GMP
As per media reports, the Grey Market Premium (GMP) of the Park Medi World IPO is reported at ₹20.5, indicating a 12.65% premium over the issue price of ₹162 per share.
Park Medi World Business Overview
Park Medi World is one of North India’s leading private healthcare providers, operating a growing network of advanced multi-super speciality hospitals. Their portfolio comprises 14 NABH-accredited hospitals, of which eight also hold NABL certification, with a total capacity of nearly 3,000 beds across the region.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.